Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States

Journal of the American Society of Nephrology

Volumn 10, Issue 8, 1999, Pages 1793-1800

  Obrador, Gregorio T ^a   Ruthazer, Robin ^a   Arora, Pradeep ^a   Kausz, Annamaria T ^a   Pereira, Brian J G ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; SERUM ALBUMIN;

ADULT; ANEMIA; ARTICLE; DEMOGRAPHY; DIALYSIS; DISEASE SEVERITY; FEMALE; GEOGRAPHY; HEALTH CARE FINANCING; HEALTH CARE QUALITY; HEMATOCRIT; HUMAN; HYPOALBUMINEMIA; INSURANCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; SOCIOECONOMICS; TREATMENT OUTCOME; UNITED STATES;

EID: 0032840297     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. U.S. Renal Data System: USRDS 1997 Annual Data Report, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 1997
2. Trend Analysis Group: National Hospital Panel Monthly Reports from January 1991 to June 1996, American Hospital Association
3. U.S. Renal Data System: USRDS 1998 Annual Data Report, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 1998
4. Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001-1006, 1993
5. Keane WF, Collins AJ: Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis 24: 1010-1018, 1994
6. Held PJ, Port FK, Wolfe RA: The dose of hemodialysis and patient mortality. Kidney Int 50: 550-556, 1996
7. Eadington D: Delayed referral for dialysis: Higher morbidity and higher costs. Semin Dial 8: 258-260, 1995
8. Obrador GT, Pereira BJG: Early referral to the nephrologist and timely initiation of renal replacement therapy: A paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis 31: 398-417, 1998
9. Port F: Morbidity and mortality in dialysis patients. Kidney Int 46: 1728-1737, 1994
10. U.S. Renal Data System: Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. Am J Kidney Dis 20: 32-38, 1992
11. McCusker FX, Teehan BP, Thorpe KE, Keshaviah PR, Churchill DN, for the Canada-USA (CANUSA) Peritoneal Dialysis Study Group: How much peritoneal dialysis is required for the maintenance of a good nutritional state? Kidney Int 50: S56-S61, 1996
12. Iseki K, Uehara H, Nishime K: Impact of initial levels of laboratory variables on survival in chronic dialysis patients. Am J Kidney Dis 28: 541-548, 1996
13. Sesso R, Belasco AG: Late diagnosis of chronic renal failure and mortality in maintenance dialysis. Nephrol Dial Transplant 11: 2417-2420, 1996
14. Barret BJ, Parfrey PS, Morgan J: Prediction of early death in end-stage renal, disease patients starting dialysis. Am J Kidney Dis 29: 214-222, 1997
15. Eschbach JW: The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin. Kidney Int 35: 134-148, 1989
16. London GM, Parfrey PS: Cardiac disease in chronic uremia: Pathogenesis. Adv Ren Replace Ther 4: 194-211, 1997
17. Silberberg JS, Barre PE, Prichard SS, Sniderman AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36: 286-290, 1989
18. Foley RN, Parfrey PS, Harnett JD: Left ventricular hypertrophy in dialysis patients. Semin Dial 5: 34-41, 1992
19. Erslev AJ, Besarab A: Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure [Editorial]. Kidney Int 51: 622-630, 1997
20. Besarab A, Ross RP, Nasca TJ: The use of recombinant human erythropoietin in predialysis patients. Curr Opin Nephrol Hypertens 4: 155-161, 1995
21. U.S. Recombinant Human Erythropoietin Predialysis Group: Double-blind, placebo controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. Am J Kidney Dis 14: 50-59, 1991
22. Lim VS: Recombinant human erythropoietin in predialysis patients. Am J Kidney Dis 18[Suppl 1]: 34-37, 1991
23. Eschbach JW, Aquiling T, Haley NR, Fan MH, Blagg CR: The long-term effects of recombinant human erythropoietin on the cardiovascular system. Clin Nephrol 38: S98-S103, 1992
24. Collins A, Ma J, Ebben J: Patient survival is associated with hematocrit level [Abstract]. J Am Soc Nephrol 8: 190A, 1997
25. Kopple JD: Effect of nutrition on morbidity and mortality in maintenance dialysis patients. Am J Kidney Dis 24: 1002-1009, 1994
26. Ikizler TA, Hakim RM: Nutrition in end-stage renal disease. Kidney Int 50: 343-357, 1996
27. Churchill D, Taylor D, Cook R: Canadian hemodialysis morbidity study. Am J Kidney Dis 19: 214-234, 1992
28. Kopple JD, Chumlea WC, Gassman JJ: Relationship between GFR and nutritional status: Results from the MDRD study [Abstract]. J Am Soc Nephrol 5: 335, 1994
29. Mitch WE: Dietary protein restriction in patients with chronic renal failure. Kidney Int 29: 734-742, 1991
30. Hood SA, Schillo B, Beane E, Rozas V, Sondheimer JH, and Members of the Michigan Renal Plan Task Force of the Michigan Public Health Institute: An analysis of the adequacy of preparation for end-stage renal disease care in Michigan. ASAIO J 41: M422-M426, 1995
31. Kopple JD, Levey AS, for the MDRD Study Group: Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney Int 52: 778-791, 1997
32. Young E, Carrol C, Wolfe R, Port F, Held P: Trends in comorbidity and residual renal function in patients starting treatment for end-stage renal disease [Abstract]. J Am Soc Nephrol 6: 569, 1995
33. Foley RN, Parfrey PS, Harnett JD: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47: 186-192, 1995
34. Levin A, Singer J, Thompson CR, Ross H, Lewis M: Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 27: 347-354, 1996
35. Hirth RA, Turenne MN, Woods JD: Predictors of type of vasv cular access in hemodialysis patients. JAMA 276: 1303-1308, 1996
36. Lameire N, Van Biesen W, Dombros N: The referral pattern of patients with ESRD is a determinant in the choice of dialysis modality. Perit Dial Int 17: S161-S166, 1997